PT Diastika Biotekindo Tbk

IDX:CHEK Stock Report

Market Cap: Rp581.9b

Diastika Biotekindo Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Franciscus Yoshua Raintjung

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenure1.2yrs

Recent management updates

No updates

Recent updates

CEO

Franciscus Yoshua Raintjung (47 yo)

less than a year
Tenure

Mr. Franciscus Xaverius Yoshua Raintjung is Corporate Secretary of PT UBC Medical Indonesia Tbk and serves as its President Director since 2021. He is President Director of PT Diastika Biotekindo since Mar...

Leadership Team

NamePositionTenureCompensationOwnership
Franciscus Yoshua Raintjung
President Directorless than a yearno datano data
Muliyati S
Head of Financeno datano datano data
Ricki Budiman
General Manager of Operationalno datano datano data
. Tyas
Legal Managerno datano datano data
Randi Guntara
Marketing Managerno datano datano data
Marcella Angelin
Finance Director & Directorless than a yearno datano data
Jeremiah Piskunov
Head of Internal Auditless than a yearno datano data
Muhammad Agustiar
Corporate Secretaryless than a yearno datano data
0.6yrs
Average Tenure
39yo
Average Age

Experienced Management: CHEK's management team is not considered experienced ( 0.6 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Franciscus Yoshua Raintjung
President Directorless than a yearno datano data
Marcella Angelin
Finance Director & Directorno datano datano data
Nathan Tirtana
President Commissioner1.8yrsno datano data
Doktoranda Theresia Nelly Susanti
Commissioner3.8yrsno data20%
IDR 116.4b
. Sundoyo
Independent Commissionerless than a yearno datano data
1.2yrs
Average Tenure
47yo
Average Age

Experienced Board: CHEK's board of directors are not considered experienced ( 1.2 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/05 20:53
End of Day Share Price 2025/10/03 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PT Diastika Biotekindo Tbk is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.